Apoptosis-associated proteins in oral hairy leukoplakia

Oral Diseases

Volumn 2, Issue 4, 1996, Pages 279-284

  Chrysomali, E ^a   Greenspan, J S ^a   Dekker, N ^a   Greenspan, D ^a   Regezi, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; Epstein Barr virus; HIV infections; immunohistochemistry; leukoplakia; oral; oral manifestations

Indexed keywords

EID: 0030470948     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1996.tb00238.x     Document Type: Article

References (18)

1. Allday MJ, Sinclair A, Parker G et al (1995). Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J 14: 1382-1391.
2. Boise LH, Gonzalez-Garcia M, Postema CE et al (1993). Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
3. Boyd JM, Gallo GJ, Elangovan B et al (1995). Bik, a novel death-inducing protein, shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11: 1921-1928.
4. Brandwein M, Nuovo G, Ramer M et al (1996). Epstein-Barr virus reactivation in hairy leukoplakia. Mod Pathol 9: 298-303.
5. Greenspan JS, Greenspan D, Lennette ET et al (1985). Replication of Epstein-Barr vims within the epithelial cells of 'hairy' leukoplakia, an AIDS-associated lesion. N Engl J Med 313: 1564-1571.
6. Greenspan JS, Greenspan D, Palefsky JM (1995). Oral hairy leukoplakia after a decade: review. Epstein-Barr Virus Rep 2: 123-128.
7. Hall PA, McKee PH, Menage HP et al (1993). High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8: 203-207.
8. Hickish T, Robertson D, Clarke P et al (1994). Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res 54: 2808-2811.
9. Hockenbery DM, Nunez G, Milliman C et al (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336.
10. Hockenbery DM, Zutter M, Hickey W et al (1991). Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965.
11. Kastan MB, Onyekwere O, Sidransky D et al (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311.
12. Krajewski S, Tanaka S, Takayama S et al (1993). Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res 53: 4701-4714.
13. Krajewski S, Krajewska M, Shabaik A et al (1994a). Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of bcl-2. Am J Pathol 145: 1323-1336.
14. Krajewski S, Krajewska M, Shabaik A et al (1994b). Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res 54: 5501-5507.
15. Lambkin HA, Mothersill CM, Kelehan P (1994). Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 172: 13-18.
16. Miyashita T, Reed J (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
17. Nakagawa K, Yamamura K, Maeda S et al (1994). Bcl-2 expression in epidermal keratinocytic diseases. Cancer 74: 1720-1724.
18. Zhang Q, Gutsch D, Kenney S (1994). Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol 14: 1929-1938.